BJ
TLOG

BlackRock Japan’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

BlackRock Japan’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,222
Closed -$7K – 1538
2015
Q4 		$7K Sell
4,222
-1,229
-23% -$2.17K ﹤0.01% 1311
2015
Q3 		$10K Sell
5,451
-836
-13% -$1.99K ﹤0.01% 1176
2015
Q2 		$15K Buy
+6,287
New +$19.4K ﹤0.01% 1235
2014
Q2 		– Sell
-565
Closed -$4K – 1490
2014
Q1 		$4K Buy
+565
New +$5.1K ﹤0.01% 1379

Other funds holding TLOG

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock Japan's TLOG Position: Q1 2016 in Review

BlackRock Japan sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 4,222 shares — an estimated $7K sold.

BlackRock Japan first reported a position in TLOG in Q1 2014 and held it in 4 quarters. The position peaked at $15K in Q2 2015. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

  • BlackRock Japan reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
  • BlackRock Japan sold 4,222 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $7K.
  • BlackRock Japan first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 4 quarters.
  • BlackRock Japan's TetraLogic Pharmaceuticals Corporation position peaked at $15K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.